Fate Therapeutics, Inc.
FATE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$32 | -$34 | -$38 | -$52 |
| Dep. & Amort. | $3 | $3 | $3 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $7 | $7 | $9 |
| Change in WC | $1 | $0 | -$5 | -$2 |
| Other Non-Cash | -$1 | -$1 | -$2 | $12 |
| Operating Cash Flow | -$24 | -$25 | -$34 | -$28 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$1 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$58 | -$51 | -$49 | -$38 |
| Inv. Sales/Matur. | $81 | $72 | $92 | $61 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $21 | $20 | $43 | $23 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $1 | $0 | $3 |
| Financing Cash Flow | $2 | $1 | $0 | $3 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1 | -$4 | $9 | -$2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $51 | $55 | $46 | $48 |
| End Cash | $51 | $51 | $55 | $46 |
| Free Cash Flow | -$27 | -$26 | -$35 | -$28 |